GI
BBIO icon

GAMMA Investing’s BridgeBio Pharma BBIO Stock Holding History

GAMMA Investing’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$133K Buy
2,020
+374
+23% +$29.1K ﹤0.01% 1650
2026
Q2 		$123K Buy
1,646
+199
+14% +$13.9K ﹤0.01% 1656
2026
Q1 		$107K Buy
1,447
+29
+2% +$2.1K 0.01% 1615
2025
Q4 		$108K Buy
1,418
+398
+39% +$26.1K 0.01% 1518
2025
Q3 		$53K Buy
1,020
+227
+29% +$11.1K ﹤0.01% 1950
2025
Q2 		$34.2K Sell
793
-127
-14% -$4.62K ﹤0.01% 2161
2025
Q1 		$31.8K Buy
920
+382
+71% +$12.9K ﹤0.01% 2113
2024
Q4 		$14.8K Buy
538
+92
+21% +$2.38K ﹤0.01% 2424
2024
Q3 		$11.4K Buy
446
+67
+18% +$1.76K ﹤0.01% 2402
2024
Q2 		$9.6K Sell
379
-12
-3% -$328 ﹤0.01% 2275
2024
Q1 		$12.1K Buy
391
+76
+24% +$2.58K ﹤0.01% 1955
2023
Q4 		$10.8K Buy
+315
New +$9.46K ﹤0.01% 1863

Other funds holding BBIO

CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

GAMMA Investing's BBIO Position: Q3 2026 in Review

GAMMA Investing increased its BridgeBio Pharma (BBIO) stake by 23% in Q3 2026, buying an estimated $29.1K and bringing the position to 2,020 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #1650.

GAMMA Investing first reported a position in BBIO in Q4 2023 and has held it in 12 quarters since. 12 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • GAMMA Investing held 2,020 shares of BridgeBio Pharma worth $133K as of Q3 2026.
  • GAMMA Investing bought 374 BridgeBio Pharma shares in Q3 2026, an estimated $29.1K.
  • BridgeBio Pharma made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1650 holding.
  • GAMMA Investing first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 12 quarters since.
  • 12 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.